secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2021-11-19T23:59:59+00:00
Accession:  0001683168-21-005846
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cannabics appoints Shaul Yemal to Board as independent director and Audit Committee member
--------------------------------------------------------------------------------

- Board expanded to five members; Shaul Yemal appointed as independent director and Audit Committee member.
- Yemal brings transnational finance experience, including roles at Israeli Ministry of Finance and Ministry of Energy.
- Previously CEO of ICL Santiago, Senior VP at ISAL Amlat VC Fund, and catalyst for Oridion Medical's IPO on Swiss exchange.
- No arrangements or understandings with any other person; no related party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316821005846/0001683168-21-005846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316821005846/cannabics_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-005846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer